chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had pain after the first vaccine and then felt better/ experiencing more pain; pulse was high after the first vaccine; This spontaneous case was reported by a patient and describes the occurrence of PAIN (had pain after the first vaccine and then felt better/ experiencing more pain) and HEART RATE INCREASED (pulse was high after the first vaccine) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 prophylaxis.     Concurrent medical conditions included Walking disability.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (had pain after the first vaccine and then felt better/ experiencing more pain) and HEART RATE INCREASED (pulse was high after the first vaccine). At the time of the report, PAIN (had pain after the first vaccine and then felt better/ experiencing more pain) had not resolved and HEART RATE INCREASED (pulse was high after the first vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: pulse was high after the first vaccine.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was on blood pressure pills for many years. Had no other heart conditions.  The patient had not taken any medication for the pain. Took a warm shower and used cool towel.   This case was linked to MOD-2022-633791 (Patient Link).
miscarriages; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer (patient's friend) reporting same event under the same suspect product for four patients. This is one of four reports. A female patient of unspecified age received bnt162b2 (Pfizer covid vaccine), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported, Caller unwilling to complete the report) as dose number unknown, single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was pregnant. The patient blamed her miscarriage on the vaccine. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101343886 same report/drug/AE, different patients
Pain in her arm; Sinus disorder; Drainage from nose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in her arm), SINUSITIS (Sinus disorder) and RHINORRHOEA (Drainage from nose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm), SINUSITIS (Sinus disorder) and RHINORRHOEA (Drainage from nose). At the time of the report, PAIN IN EXTREMITY (Pain in her arm), SINUSITIS (Sinus disorder) and RHINORRHOEA (Drainage from nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medications reported. no treatment details reported.
"I had the 'usual' reaction to the vaccine a week ago on Friday (1/8)--sore, red lump on arm, headache/body aches/fatigue. Everything except the arm was gone by Sunday (1/10). I took some Benadryl on Sunday and the arm appeared to be getting better. The hard lump never went away though and by Friday (1/15) it was huge, red, hot and swollen. Long story short, I ended up with a whopping case of cellulitis and am on some antibiotics. The Dr. was not sure who I should report it to...there's certainly the possibility that it's random (I could have ended up with cellulitis even if I was getting a tetanus vaccine or something and I realize that) or if it could be connected to the vaccine not dispersing in my arm?
Generalized macular rash developed on 09/19.  Child had low grade fevers and was fussy.
Pain at injection site and surrounding muscle starting 05/11/2016. Swollen lymph nodes in neck starting 05/12/2016.
Concomitant products included LEVOTHYROXINE and CELECOXIB (CELEBREX) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles), RASH (rash only in her abdomen and back and lower part of the body) and PAIN (significant pain). At the time of the report, HERPES ZOSTER (shingles), RASH (rash only in her abdomen and back and lower part of the body) and PAIN (significant pain) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Fever; headaches; Fatigue; This is a spontaneous report received from a contactable consumer. A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had a reaction after second dose: fever, headaches, fatigue, that persisted for several days after. The outcome of events was recovered on an unspecified date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Hives on back, arms, and stomach.  Teledoc prescribed Mometasone 0.1% cream, some relif,  outbrakes continued and I went to my PCM on the following Wednesday and received a steroid shot,  hives continued and continued for about 5 months.
ADMINSITERED PAST THE CURRENT REFIRIGERATION BEYOND USE DATE AS LISTED IN EUA
03/28/2022 Chest congestion, Inflamation of the Lungs that lasted four weeks. Nebulizer treatment one treatment, Ashma Inhaler for 24 hours and Steriods for two weeks. No longer under doctor care.
flu-like symptoms; This case was reported by a physician via call center representative and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported.  The age group was not reported but was selected as an adult per the vaccine indication. The reporter stated that, the patient received the first dose of Shingrix and afterwards experienced flu like symptoms. The Healthcare professional would like to know clinical data after receiving just 1 dose of Shingrix. No information provided on patient.
This spontaneous report was received from a Licensed Practical Nurse via company representative regarding multiple patients of unknown demographics. Information on pertinent medical history, drug reactions/allergies and concomitant medications was not reported. On multiple unspecified dates, the patients received ROTATEQ orally (dose, frequency, lot# and expiry dates were not reported). The nurse reported that since the start (1 or 2 years ago) of ROTATEQ, it was noticed that many patients either spit up or vomit after receiving the vaccine. No other adverse effects were reported. Outcome and causality of the events were not reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Day after: nausea & dizzy first for a few hours. Labored breathing most of day. General body aching and joints aching. Slight headache throughout day.
G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/28/2023 ESOPHAGEAL VARICES G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/28/2023 ANEMIA G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/28/2023 ANEMIA G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/28/2023 ESOPHAGEAL VARICES G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/28/2023 ESOPHAGEAL VARICES
temperature for a week,  was up to 102 with tylenol at one point, red lump on arm still noticeable after one week,  arm sore when lifting still,
Case number PHEH2015US026867, is an initial spontaneous report received from a nurse on 22 Dec 2015. This report refers to a 39-years-old male patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer unknown, batch number: 1514501 and expiry date: May 2016) in left deltoid on 26 Oct 2015, which was out of temperature range (34 degrees). The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day the temperature was fine. It was a new refrigerator and there have not been any problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. No further information was provided. Follow up information received from the nurse on 26 Jan 2016: Reporter comment updated.
Redness at injection site, warm to touch, reaction spread over next day over both injection sites-was seen at the doctor and told it was cellulitis-treated with Clindamycin.
Initial report received from a health care professional on 23 September 2011. This reporter also reported another adverse event, which was captured in case number 2011-11123 and 2011-11124. This is a non-valid case: Patient identifiers and vaccine lot numbers are missing. This case involves a cluster of unidentified patients with the same reporter, same vaccine (FLUZONE, however lot numbers were unknown) and same event of cellulitis. Three unidentified patients had received a dose of FLUZONE (lot number unknown) on an unspecified date in 2011 and on an unspecified date following vaccination in 2011 they developed cellulitis at the site. The reporter had no additional information to provide at the time of this report, but reported more information would be provided on follow-up. Recovery status for the three patients were not reported. Follow-up information received from a health care professional on 14 November 2011 identified this case as a 63-year-old female patient who received a right arm injection of FLUZONE, sanofi pasteur Inc. lot number UH454AC, on 13 September 2011. The patient had an allergy to sulfa. On 15 September 2011, the patient was seen in the Emergency Department (ED) and diagnosed with cellulitis of the right arm with symptoms of fever and chills. The patient was treated with KEFLEX. The outcome was reported as unknown. Documents held by sender: None.
Received vaccine 12/29/20.  Next day started having right rib/ gastric pressure, fullness.  1/1/21 started having abd pain, loose stools. 1/2/21 went to ER and had CT abd.  Diagnoses colitis with extensive peri portal edema in liver.  No history of any liver or GI issues except IBS.  MD not sure if related to covid vaccine or not.  Liver enzymes normal.  Started on antibiotics.
Patient stopped progressing after 18 month shots. he has been diagnosed autistic. He is lacking in many areas, i.e. potty training, language, social skills, behavior. His behavior is volatile. He bites, head slams, and is very physical with my 5.5 year old girl. I noticed all of these things within days. Follow up:Fever developed after vaccination. Mom treated it with alternating doses of Tylenol and Motrin x 2 days.  Nurse follow up on 10/20/04 states: "Medical records review confirms diagnosis of autism."  Per the follow up report-Patient is delayed in so many areas except motor skills. He is not wanting to potty train. He eats non-edible items such as pencils, chalk, porcelain and wood. He is self injuting when angry or upset. His language is less than 24 month. He is very destructive in the home such as breaking glass and flipping furniture. On occasion, this school year, he has shown some aggression towards classmates. He cannot sleep more than 2-3 hours per night without medication. He is currently taking Clonidine 0.1M, Trazodone 50 mg, Seroquel 25 mg, once daily at bedtime. He is obsessive with man things like certain foods, certain movies, toys and closing doors. He is also obsessed with water and is unaware of danger about water. He does not understand about fear like fire, cars in the road, climbing, breaking glass with his bare hands. He bites often and sometimes so severe he can break the skin through clothing hisself and daughter as well. I feel like this is a pretty good picture of patient. I could go on and on.
It seems that when the vaccine was administered, it hit a blood vessel and perhaps a nerve. The site of the injection bled and I had a burning pain with a circular red spot below the injection site. I have a bruise that is still there. It has been two weeks and I still have pain, burning and a heavy, somewhat numb feeling in my left upper arm. I experienced a headache for one week and nausea for a few days.
pt recv vax & as pt rose to leave felt light-headed but stood & walked out of room holding onto mom & said "uh oh" & fell was unconscious about 1min;noted mild muscle jerking of arms & legs;referred to ER or MD-mom decided against;
patient passed away subsequent to receiving dose on 02/01. Staff does not have reason to believe vaccine was involved.
Swelling and redness from injection site down to elbow.  Erythematous, swollen and very painful.
Pt recv vax on 8/29/97; post vax pt exp alopecia, facial rash & swelling
No adverse reaction, but patient was given a Senior Flu vaccine instead of the regular Flu dose. Patient is only 62, and so not yet the required age for the Senior Flu.
pt recv vax 11MAY98 & 15MAY98 pt was found to have a positive HBSAG;pt placed in isolation;eventual diagnosis was hepatitis B;
No symptoms reported.; patient received unspecified dose of either a VARIVAX or a PROQUAD dose that was improperly stored.; Information has been received from a medical assistant, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 06-FEB-2020, the patient received unspecified dose of either a varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose and route were unknown; lot # S025610, expiration date 18-AUG-2021) or measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, dose and route were unknown; lot # S0l7250, expiration date 01-DEC-2020) for prophylaxis, that was improperly stored. sterile diluent was properly stored. The vaccine was exposed to temperature excursion at 7.5 degrees Fahrenheit for 15 minutes (incorrect product storage). There was no previous temperature excursion. The call was due to digital data logger. No symptoms were reported.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 28-DEC-2011, a pharmacist at a pharmacy administered the ZOSTAVAX vaccine to the patient (lot number, dosage and route of administration not provided). In September 2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity, and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Started with what I thought were bug bites on face and neck.  Later it had spread and it was clear it wasn't bug bites.  Saw Dr. on 1st and was placed on prednisone...rash seem to get better but apx 5 days after prednisone was completed experienced severe headache and some muscle aches, two days later nausea and dizziness set in, the next day vomiting started (minimal if I didn't move I didn't vomit) a second course of prednisone started on day 7 after completing 1st course although this didn't help with nausea and vomiting.  Rash which had started to reoccur seemed to clear up with 2nd dose.  7/21 (report date) rash is still there but seems to be getting better.  Nausea has returned today but not as bad 2nd does of prednisone was just recently completed.
A 35 year old female consumer had titers drawn and showed no evidence of adequate immunity.; This spontaneous report has been received from a nurse, concerning a 35-years- old female patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided.  On an unknown date, the patient was administered vaccine measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (dose, dose number vaccination scheme, frequency, lot number, and expiration date were not provided) for prophylaxis.  On an unknown date, the patient experienced titers drawn and showed no evidence of adequate immunity (antibody test negative). The patient sought medical attention, and laboratory diagnostics were performed. Additionally, it was unknown by the reporter if she received any treatment. The outcome of the event antibody test negative was not provided.  The causality assessment between the event antibody test negative and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not reported.
some foods now taste like chemicals; Allergic reactions where none existed before/ new allergies keep popping up/ having allergies left and right, its like my body is in hyperactive state; The initial safety information received was reporting only non-serious adverse drug reactions, Upon receipt of follow-up information on 29Sep2021, this case now contains serious adverse reactions. Information processed together.  This is a spontaneous report from a contactable consumer (patient).  A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in the left arm on 10Feb2021 13:00 (Batch/Lot Number: EN5318) (at the age of 50-years-old) as DOSE 2, SINGLE for COVID-19 immunisation.  Medical history included polycythaemia vera from May2019 and ongoing, allergies: antihistamines, steroids, allergic to different meds, environmental allergy, and allergic to different foods (bananas taste like a weird sweet chemical and other food) from unknown dates and unknown if ongoing. Concomitant medications included probiotics and multivitamains  taken for an unspecifed indication, start and stop date were not reported.  Patient was not pregnant at time of vaccination. The vaccination was performed in a nursing home/ senior living facility. The patient had no prior vaccination received within 4 weeks prior to the COVID-19 vaccine. The patient previously took antihistamines and steroids and experienced allergies. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19) intramuscular, administered in the left arm on 20Jan2021 11:00 (Batch/Lot Number: EL3249) (at the age of 50-years-old) as DOSE 1, SINGLE for COVID-19 immunization and experienced nasal swab positive/ Covid test result: positive on 21Jan2021. On 28Mar2021, the patient experienced allergic reactions where none existed before/ new allergies keep popping up/ having allergies left and right, its like my body is in hyperactive state/ sudden onset of allergies On 29Mar2021, some foods now taste like chemicals. The patient reported within 4 weeks of 2nd dose of Pfizer vaccine, she had been having allergies left and right, its like her body was in hyperactive state. Even allergic to antihistamines, steroids and different meds and food. Allergist did not know what to do, she cannot take allergy shots, nothing. If she did not have allergic reactions to the food, different foods taste like chemical. Bananas taste like a weird sweet chemical and other food. The events were considered serious due to significant disability/ incapacity. The events required emergency room, physician's office visit, and treatment (had to see allergist, still had  no answers). The patient underwent nasal swab: positive on 21Jan2021 day after COVID 1st dose of vaccine. The outcome of the events was not recovered.  No Follow-up attempts are needed. No further information is expected.
lost use of my right arm which is my predominant arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization, reaction(s): "After my first covid vaccine dose, I slept". The following information was reported: MONOPLEGIA (medically significant), outcome "not recovered", described as "lost use of my right arm which is my predominant arm".  Clinical information: After the first Covid vaccine dose, the patient slept. After the second Covid vaccine dose, the patient lost use of right arm which was the predominant arm and the patient still did not have close to total range of motion. There was no way the patient would receive a booster. This had cost the patient much money.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
A staff member presented at a second clinic on this campus, but she was given her first dose just 13 day previously, so it was 4 days too soon
Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/6/2021 and 3/27/2021. Patient was recently hospitalized for COVID-19 from 8/23/2021 to 8/26/2021. Patient presented to ED on 8/27/2021 due to repeated hypoxia. Dexamethasone and cefuroxime was administered. Throughout hospitalization, patient had significant change in mental status and continued weakness. Palliative care was consulted on 9/4/2021 and patient expired at 06:37 on 9/8/2021.
Took Covid-19 Booster through Pfizer, the next few days later had swollen hands, itchy limbs, full body hives, rash, ongoing swollen tongue, uticaria, persistent allergic reaction for over a year now. Had to go to allergist, taking high dosage of antihistamine and xolair to mitigate ongoing side effects.
Fever and focal seizure < 24 hour after Imm's given. Had mild URI sx.